Potential Impact of USPSTF Recommendations on Early Diagnosis of Breast Cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Current US Preventive Services Task Force (USPSTF) guidelines recommend against routine screening mammography in women aged 40–49 years. However, diagnosis of early-stage breast cancer relies on mammographic screening for detection. We hypothesized that screening at younger age may be important for detecting earlier and more treatable cancers for women in different demographic groups.
All women with ductal carcinoma in situ (DCIS) or T1N0 breast cancer between 2004 and 2008 in the California Cancer Registry were evaluated. Patients were divided into: (1) women aged 40–49 years, who would be excluded from USPSTF recommendations for screening, and (2) women aged 50–74 years, who are recommended for screening. Patients in the two age groups were compared by race/ethnicity, socioeconomic status (SES), and hormone receptor (HR), human epidermal growth factor receptor 2 (HER-2), and triple-negative (TN) status.
Of 46,691 patients identified, 22.6% were aged 40–49 years, and 77.4% were aged 50–74 years. Younger women with DCIS had statistically higher odds of being HR positive and having higher SES, and Hispanic and Asian/Pacific Islander (PI) race/ethnicity, while younger women diagnosed with T1N0 breast cancer had higher odds of being HR positive, HER-2 positive, and triple negative and of having higher SES and non-white race/ethnicity.
Young Hispanic, Asian/PI, and non-Hispanic (NH) Black women in California have greater odds of being diagnosed with early breast cancer than their older counterparts. Excluding 40–49-year-old women from screening could impact early diagnosis of HR-positive, HER-2-positive, and TN tumors. Implementation of USPSTF recommendations could disproportionately impact non-white women and potentially lead to more advanced presentation at diagnosis.
- Altekruse SF KC, Krapcho M, et al. (eds) SEER cancer statistics review, 1975–2007, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Bethesda, MD: National Cancer Institute. 2010. http://seer.cancer.gov/csr/1975_2007/. Accessed 1 April, 2011.
- Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–92. CrossRef
- Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738–47.
- Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359(9310):909–19. CrossRef
- Cady B, Michaelson JS, Chung MA. The “tipping point” for breast cancer mortality decline has resulted from size reductions due to mammographic screening. Ann Surg Oncol. 2011;18(4):903–6. CrossRef
- Virnig BA, Wang SY, Shamilyan T, Kane RL, Tuttle TM. Ductal carcinoma in situ: risk factors and impact of screening. J Natl Cancer Inst Monogr. 2010;(41):113–16.
- Hofer BM KS, Allen M, Bates JH, Snipes KP. Cancer in california 1988–2007. Sacramento, CA: California Department of Public Health, Cancer Surveillance Section.
- Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH (2004) The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 42(5):793–806. CrossRef
- Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet. 2006;368(9552):2053–60. CrossRef
- U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26, W-236.
- Newman LA. Breast cancer in African–American women. Oncologist. 2005;10(1):1–14. CrossRef
- Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24(9):1342–9. CrossRef
- Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703–11. CrossRef
- Olaya W, Wong J, Morgan J, et al. Factors associated with variance in compliance with a sentinel lymph node dissection quality measure in early-stage breast cancer. Ann Surg Oncol. 2010;17(0):297–302. CrossRef
- Olaya W, Wong JH, Morgan JW, Roy-Chowdhury S, Lum SS. Disparities in the surgical management of women with stage I breast cancer. Am Surg. 2009;75(10):869–72.
- Mook S, Van’t Veer LJ, Rutgers EJ, et al. Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst. 2011;103(7):585–97. CrossRef
- Smart CR, Byrne C, Smith RA, et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin. 1997;47(3):134–49. CrossRef
- Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst. 2005;97(16):1195–203. CrossRef
- Wishart GC, Greenberg DC, Britton PD, et al. Screen-detected versus symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer. 2008;98(11):1741–4. CrossRef
- Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 151(10):727–37, W237–742.
- Kopans DB. The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: the scientific support for mammography screening. Radiol Clin North Am. 2010;48(5):843–57. CrossRef
- Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 2011;196(2):W112–6. CrossRef
- Miranda PY, Wilkinson AV, Etzel CJ, et al. Policy implications of early onset breast cancer among Mexican-origin women. Cancer. 2011;117(2):390–7. CrossRef
- Risendal B, Hines LM, Sweeney C, et al. Family history and age at onset of breast cancer in Hispanic and non-Hispanic white women. Cancer Causes Control. 2008;19(10):1349–55. CrossRef
- Innos K, Horn-Ross PL. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women. Cancer. 2003;97(4):1099–106. CrossRef
- U.S. Census Bureau (2010). http://2010.census.gov/2010census/ Accessed 1 April, 2011.
- Nassar H, Sharafaldeen B, Visvanathan K, Visscher D. Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome. Cancer. 2009;115(14):3181–8. CrossRef
- Hofer BM KS, Allen M, Bates JH, McCusker ME, Snipes KP. Cancer in California, 2008, special highlight on cancer by race and ethnicity. Sacramento, CA: California Department of Public Health, Cancer Surveillance Section.
- Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541–53.
- Hahn KM, Bondy ML, Selvan M, et al. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol. 2007;166(9):1035–44. CrossRef
- Wells BL, Horm JW. Stage at diagnosis in breast cancer: race and socioeconomic factors. Am J Public Health. 1992;82(10):1383–5. CrossRef
- Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490–6.
- Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast J. 2009;15(6):593–602. CrossRef
- Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492–502. CrossRef
- Health and Safety Code Section 103875–103885. http://www.leginfo.ca.gov/cgi-bin/displaycode?section=hsc&group=103001-104000&file=103875-103885. Accessed 4 June, 2011.
- Potential Impact of USPSTF Recommendations on Early Diagnosis of Breast Cancer
Annals of Surgical Oncology
Volume 18, Issue 11 , pp 3137-3142
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Division of Surgical Oncology, Loma Linda University School of Medicine, Loma Linda, CA, USA
- 2. School of Public Health, Loma Linda University, Loma Linda, CA, USA
- 3. Desert Sierra Cancer Surveillance Program, Loma Linda University Medical Center, Loma Linda, CA, USA
- 4. Department of Surgery, Division of Surgical Oncology, Brody School of Medicine, East Carolina University, Greenville, NC, USA